内耳显影对迟发性膜迷路积水诊断的意义

The Application of Endolymphatic Space Imaging in the Diagnosis of Delayed Endolymphatic Hydrops

吴倩如;张国明;赵梦龙;沙炎;戴春富;

1:复旦大学附属眼耳鼻咽喉科医院耳神经颅底外科

2:卫生部听觉医学重点实验室

3:浙江省绍兴市第五人民医院耳鼻咽喉科

4:复旦大学附属眼耳鼻咽喉科医院放射科

摘要
目的明确鼓室内钆造影剂注射后内耳显影对迟发性膜迷路积水(delayed endolymphatic hydrops,DEH)诊断的临床价值,探讨迟发性膜迷路积水的病理机制。方法 10例DEH患者行双鼓室钆造影剂注射24小时后行三维快速液体衰减反转恢复(three dimensional fluid-attenuated inversion recovery,3D-FLAIR)序列和三维实时反转恢复(three dimensional real inversion recovery,3D-real IR)序列扫描成像,分析患者内淋巴积水的范围及严重程度。结果 10例DEH患者中9例为同侧型,1例为对侧型,均显示单侧或双侧内淋巴积水征象,其中9例同侧型DEH患者中仅1例(11.1%)患侧耳前庭内淋巴显示轻度积水,其余8例(88.9%)均显示患侧前庭内淋巴重度积水;8例(88.9%)同侧型DEH患者患侧耳蜗内淋巴积水,而1例(11.1%)同侧型DEH患者患侧耳蜗内淋巴无积水,9例同侧DEH患者对侧耳均未见前庭、耳蜗内淋巴积水。1例对侧型DEH患者的双侧前庭内淋巴重度积水,右侧耳蜗内淋巴轻度积水,而左侧耳蜗未见积水。结论内淋巴积水是DEH的主要病理因素,鼓室内钆注射后内耳显影能直观地反映出DEH患者内淋巴积水的范围及严重程度。
关键词
迟发性膜迷路积水;内耳显影;鼓室内注射
基金项目(Foundation):
国家自然科学基金(81070785;81170909);; 卫生公益行业专项基金(201202001)资助
作者
吴倩如;张国明;赵梦龙;沙炎;戴春富;
参考文献

1 Kamei T,Noro H,Yabe K,et al.Statistical observation of unilateral total deafness and characteristics of unilateral total deafness among young children with tendency toward dizziness[J].Jibiinkoka,1971,43:349.

2 Nadol JJ,Weiss AD,Parker SW.Vertigo of delayed onset after sudden deafness[J].Ann Otol Rhinol Laryngol,1975,84:841.

3 Wolfson RJ,Leiberman A.Unilateral deafness with subsequent vertigo[J].Laryngoscope,1975,85:1762.

4 Schuknecht HF.Delayed endolymphatic hydrops[J].Ann Otol Rhinol Laryngol,1978,87:743.

5 Schuknecht HF,Suzuka Y,Zimmermann C.Delayed endolymphatic hydrops and its relationship to Meniere's disease[J].Ann Otol Rhinol Laryngol,1990,99:843.

6 Nakashima T,Naganawa S,Sugiura M,et al.Visualization of endolymphatic hydrops in patients with Meniere's disease[J].Laryngoscope,2007,117:415.

7 Nakashima T,Naganawa S,Katayama N,et al.Clinical significance of endolymphatic imaging after intratympanic gadolinium injection[J].Acta Otolaryngol,2009,129:9.

8 Giannoni B,Pagnini P,Vannucchi P.Delayed endolymphatic hydrops[J].Acta Otorhinolaryngol Ital,1998,18:66.

9 Albernaz PL.Unusual cases of delayed endolymphatic hydrops[J].Acta Otolaryngol,2007,127:355.

10 Komatsuzaki A,Futaki T,Harada Y,et al.Delayed endolymphatic hydrops.The guideline for standardization of diagnostic criteria in vertiginous diseases.The Committee for Standardization of Diagnostic Criteria in 16Vertiginous Disease[J].Equilibrium Res(Kyoto),1987,47:249.

11 Nakashima T,Naganawa S,PyykkI,et al.Grading of endolymphatic hydrops using magnetic resonance imaging[J].Acta Oto-laryngologica,2009,129:5.

12 Nonoyama H,Tanigawa T,Tamaki T,et al.Evidence for bilateral endolymphatic hydrops in ipsilateral delayed endolymphatic hydrops:preliminary results from examination of five cases[J].Acta Otolaryngol,2014,134:221.

13 Harris JP,Aframian D.Role of autoimmunity in contralateral delayed endolymphatic hydrops[J].Am J Otol,1994,15:710.

14 Suzuki M,Hanamitsu M,Kitanishi T,et al.Autoantibodies against inner ear proteins in patients with delayed endolymphatic hydrops and unilateral juvenile deafness[J].Acta Otolaryngol,2006,126:117.

15 Shojaku H,Watanabe Y,Takeda N,et al.Clinical characteristics of delayed endolymphatic hydrops in Japan:A nationwide survey by the Peripheral Vestibular Disorder Research Committee of Japan[J].Acta Otolaryngol,2010,130:1135.

16 Huygen PL,Admiraal RJ.Audiovestibular sequelae of congenital cytomegalovirus infection in 3children presumably representing 3symptomatically different types of delayed endolymphatic hydrops[J].Int J Pediatr Otorhinolaryngol,1996,35:143.

17 Kamei T.Delayed endolymphatic hydrops as a clinical entity[J].Int Tinnitus J,2004,10:137.

18 Ohki M,Matsuzaki M,Sugasawa K,et al.Vestibular evoked myogenic potentials in ipsilateral delayed endolymphatic hydrops[J].ORL J Otorhinolaryngol Relat Spec,2002,64:424.

19 Ohki M,Matsuzaki M,Sugasawa K,et al.Vestibular evoked myogenic potentials in patients with contralateral delayed endolymphatic hydrops[J].Eur Arch Otorhinolaryngol,2002,259:24.